FARMSTANDART-UFAVITA, JSC ,   Russia

A solution for subcutaneous administration, 20 mg / ml.

Solution for intravenous and intramuscular injection, 500 mg / ml.

Tablets dispersible in the oral cavity, 60 mcg and 120 mcg.

Solution for intramuscular injection 6 mg / ml.

Solution for intradermal administration, 2 TE / dose.

Lyophilizate for the preparation of a suspension for intramuscular administration of prolonged action, 3.75 mg.

Dragee by 50 and 100 mg.

For 10 dragees in a contour mesh package made of a film of polyvinylchloride or light-protective film and aluminum foil, 25 dragees in cans of polymer. Each jar or 1 or 2 contour packs together with the instruction for use is placed in a pack of cardboard. 60 cans of polymer or 150 contour packs with an equal number of instructions for use are placed in a group package.

Solution for intravenous administration, 20 mg / ml.

Tablets, 100 mg.

Film-coated tablets, 150 mg and 500 mg.

Lyophilizate for the preparation of solution for intravenous and intramuscular injection 50 mg.

Tablets chewing for children.

Tablets are chewing [mint].

Tablets chewing [orange].

The tablets covered with a cover.

The tablets covered with a cover.

The tablets covered with a cover.

The tablets covered with a cover.

Solution for intramuscular, intravenous and parabulbar injection, 100 mg / ml.

Solution for injection, 10 mg / ml.

Solution for intravenous and subcutaneous administration, 50 μg / ml, 100 μg / ml, 300 μg / ml.

Microspheres for suspension preparation for intramuscular administration of prolonged actions containing 10 mg, 20 mg and 30 mg of octreotide.

Solution for intravenous and intramuscular injection 200 mg / ml.

Tablets, film-coated, 80 mg.

Capsules, 50 mg and 100 mg.